The viewer should carefully consider before reading, accepting, or using in any way the information provided.
By accessing the following section of our website, you are accepting to be subject to the terms and conditions hereby notified, which may be modified or updated (and for such reason, it should be read thoroughly before every access).
The admission document published in this section of the website (“Admission Document”) was drafted in compliance with the issuers regulation of AIM Italia / Alternative Capital Market (“AIM Issuers Regulation”) for the purposes of admitting the ordinary shares of Farmaè S.p.A. (the “Company”) on this multilateral trading system organized and managed by Borsa Italiana S.p.A.
The offer of financial instruments contemplated in the Admission Document and any other information contained in the following pages do not constitute a “public offer”, as defined by Legislative Decree 24 February 1998, no. 58 (“TUF”), and therefore it is not necessary to draw up a prospectus according to the schemes provided by Community Regulation 809/2004 / EC.
The Admission Document does not therefore constitute a prospectus and its publication must not be authorized by CONSOB pursuant to Community Directive no. 2003/71 / EC or any other regulation or rule governing the drafting and publication of information prospectuses pursuant to articles 94 and 113 of Legislative Decree 24 February 1998, no. 58 TUF, including the issuer regulation adopted by CONSOB with resolution no. 11971 of May 14, 1999, as subsequently amended and supplemented.
The information contained in this section of the website is disseminated in accordance with articles 17 and 26 of the AIM Issuers Regulation.
This section of the website, the Admission Document and any other information contained in the following pages are accessible only by persons who: (i) are resident in Italy and who are not domiciled or otherwise currently located in the United States of America, Australia, Japan, Canada as well as in any other country where the dissemination of the Admission Document and / or such information requires the approval of the competent local Authorities or is in violation of local laws or regulations (“Other Countries”); and (ii) are not “U.S. Person “, as defined in Regulation S of the 1993 United States Securities Act, as subsequently amended, nor are they persons acting on their behalf or for their benefit without the existence of a specific registration or a specific exemption to registration provided under the United States Securities Act and the current legislation.
A “U.S. Person” in the meaning above is precluded from any possibility of accessing this section of the website, temporary or permanent download, storage and / or saving of the Admission Document and any other information contained in this section of the website. The information contained in this section of the website cannot be copied or forwarded.
For no reasons and under no circumstances the Admission Document and any other information contained in this section of the website may be circulated, directly or through third parties, to subjects who are in the conditions referred to in points (i) and (ii) of the preceding paragraph and, in particular, in the United States, in Australia, in Japan, in Canada or in the Other Countries.
The information contained in this website (or in any other website with which this website has hyperlinks) does not constitute an offer, invitation to offer, or promotional activity in relation to the ordinary shares of Farmaè S.p.A. towards any citizen or person resident in the United States, Australia, Japan, Canada or in the Other Countries. Furthermore, the Company’s financial instruments are not, and will not be, registered pursuant to the 1993 United States Securities Act, as amended, or by any regulatory authority of any state or other United States jurisdiction and cannot be offered or sold in the United States or to, or on behalf and for the benefit of, a “US Person “, as defined below, in the absence of the aforementioned registration or express exemption from such performance, or in Australia, Japan, Canada or in Other Countries.
Regulation S of the 1993 United States Securities Act, as subsequently amended, defines “U.S. Person “: (a) any natural person resident in the United States; (b) “partnerships” and “corporations” established and organized according to the legislation in force in the United States; (c) any property whose directors or managers are a “U.S. Person”; (d) trusts whose trustee is a “U.S. Person”; (e) any agency or branch of a person based in the United States; (f) non-discretionary accounts; (g) other similar accounts (except for property or trust), managed or administered by trust on behalf or for the benefit of a “U.S. Person “; (h) “partnerships” and “corporations” if (i) incorporated and organized under the laws of any foreign jurisdiction; and (ii) consisting in a “U.S. Person” whose main objective is investing in securities which are not registered under the 1993 United States Securities Act, as subsequently amended, unless they are established or organized and owned by accredited investors (as defined in the United Rule 501 (a) of the 1993 United States Securities Act) which are not natural persons, properties or trusts.
Tin order to access this section of the website, the Admission Document and any other information contained on the following pages, I declare under my full responsibility that I am resident in Italy and I am not neither domiciled nor currently located in the United States of America, in Australia, Japan, Canada or the Other Countries nor a “US Person “as defined in Regulation S of the 1993 United States Securities Act, as subsequently amended.